NEULAND LABORATORIES LTD. - 524558 - Audio Recording Of The Earnings Call Conducted On November 10, 2022
Audio Recording of the earnings call conducted on November 10, 202211-11-2022
11-11-2022
NEULAND LABORATORIES LTD. - 524558 - Unaudited Financial Results For The Quarter And Half Year Quarter And Half Year Ended September 30, 2022, Along With The Press Release And Investor Presentation.
Unaudited Financial Results for the quarter and half year quarter and half year ended September 30, 2022, Along With The Press Release And Investor Presentation.10-11-2022
NEULAND LABORATORIES LTD. - 524558 - Unaudited Financial Results For The Quarter And Half Year, Along With The Press Release And Investor Presentation.
Unaudited Financial Results for the quarter and half year, Along With The Press Release And Investor Presentation.10-11-2022
NEULAND LABORATORIES LTD. - 524558 - Disclosure Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201510-11-2022
Neuland Labs hits 20% upper circuit after solid Q2; stock at 10-month high
The company reported a record EBITDA margin of 23.6 per cent, led by shift in business mix towards higher margin products as well as various cost optimization initiatives.10-11-2022
NEULAND LABORATORIES LTD. - 524558 - Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2022
Unaudited Financial Results For The quarter and half year ended September 30, 202210-11-2022
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Mr. Prasad Raghava Menon (DIN: 00005078) as an Additional Director, categorized as Independent, on the Board of the Company.31-10-2022
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Revised Earnings Call Intimation for Q2 FY202328-10-2022
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Earnings Call Intimation Q2 FY202328-10-2022
NEULAND LABORATORIES LTD. - 524558 - Statement Of Investor Complaints For The Quarter Ended September 2022 (Revised)
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Sarada BhamidipatiDesignation :- Company Secretary and Compliance Officer17-10-2022